Peripheral markers of oxidative stress in probable Alzheimer patients

European Journal of Clinical Investigation

Volumn 29, Issue 7, 1999, Pages 643-649

  Repetto, M G ^a   Reides, C G ^a   Evelson, P ^a   Kohan, S ^a   De Lustig, E S ^a   Llesuy, S F ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Alzheimer's disease; Antioxidant parameter; Catalase; Chemiluminescence; Oxidative stress; Peripheral markers; Total radical trapping

Indexed keywords

ANTIOXIDANT; CATALASE; HEMOGLOBIN; OXYGEN RADICAL; TERT BUTYL HYDROPEROXIDE; TROLOX C;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BIOCHEMISTRY; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE MARKER; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MALE; OXIDATIVE STRESS; PATHOLOGY; PRIORITY JOURNAL;

EID: 0033035115     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00506.x     Document Type: Article

References (30)

1. 1 Sies H. Oxidative stress: introductory remarks. In: Sies H, editor. Oxidative stress San Diego: Academic Press; 1985, p.1-7.
2. 2 Haliwell B, Gutteridge J. Oxygen is poisonous - an introduction to oxygen toxicity and free radicals. In: Haliwell B, Gutteridge J, editors. Free radicals in biology and medicine. Oxford: Clarendon Press; 1989. p.1-21.
3. 3 Oertel WH, Bandmann O, Eichhorn T, et al. Peripheral markers in Parkinson's disease. In: Battistin L, Scarlato G, Caraceni T, Ruggieri S, editors. Advances in neurology. Philadelphia: Lippincott-Raven; 1996. p.283-91.
4. 4 Pryor W, Godber SS. Noninvasive measures of oxidative stress status in humans. Free Rad Biol Med, 1991;10:177-84.
5. 5 Lissi E, Salim-Hanna M, Pascual C, del Castillo M. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol enhanced chemiluminescence measurements. Free Rad Biol Med, 1995;18:153-8.
6. 6 Llesuy S, Milei J, Gonzalez Flecha B, Boveris A. Myocardial damage induced by doxorubicins: hydroperoxide-initiated chemiluminescence and morphology. J Free Rad Biol Med, 1990;8:259-64.
7. 7 Ferreira R, Llesuy S, Milei J, et al. Assessment of myocardial oxidative stress in patients after myocardial revascularization. Am Heart J, 1988;115:307-12.
8. 8 Llesuy S, Evelson P, Gonzalez Flecha B, et al. Oxidative stress in muscle and liver of rats with septic syndrome. Free Rad Biol Med, 1994;16:445-51.
9. 9 Ceballos I, Agid F, Delacourte A, et al. Parkinson's disease and Alzheimer's disease: Neurodegenerative disorders due to brain antioxidant system deficiencies? In: Emerit I, Packer L, Auclair C, editors. Advances in experimental biology and medicine antioxidant in therapy and preventive medicine. New York: Plenum Press; 1990. p.493-8.
10. 10 Volicer L, Crino P. Involvement of free radicals in dementia of the Alzheimer's type: a hypothesis. Neurobiol Aging, 1990;11:567-71.
11. 11 Subarao K, Richardson S, Ang L. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem, 1990;55:342-5.
12. 12 Balazs L, Leon M. Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem Res, 1994;19:1131-7.
13. 13 Papolla M, Omar R, Kim K, Robakis N. Immunohistochemical evidence of antioxidant stress in Alzheimer's Disease. Am J Pathol, 1904;140:621-8.
14. 14 Chen L, Richardson J, Caldwell J, Ang L. Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls. Int J Neurosci, 1994;75 (1-2):83-90.
15. 15 Zemlan F, Thienhaus O, Bosman H. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Brain Res, 1989;476:160-2.
16. 16 Lustig E, Serra J, Kohan S, Canziani G, Famulari A, Dominguez R. Copper-zinc Superoxide dismutase activity in red blood cells and serum in demented patients and in aging. J Neurol Sci, 1993;115:18-25.
17. 17 Ceballos-Picot I, Merad-Boudia M, Nicole A, et al. Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type-place of the extracellular glutathione peroxidase. Free Rad Biol Med, 1996;20:579-87.
18. 18 Hamilton M. Rating scale for depression. J Neurol Neurosurg Psychiat, 1960;23:56-62.
19. 19 Lissi E, Pascual C, Del Castillo M. Luminol luminescence induced by 2, 2'-Azo-bis (2-amidinopropane) thermolysis. Free Rad Res Comm, 1992;17:299-311.
20. 20 Repetto M, Reides C, Gomez Carretero M, Costa M, Griemberg G, Llesuy S. Oxidative stress in blood of HIV infected patients. Clin Chim Acta, 1996;255:107-17.
21. 21 Chance B. Special Methods: Catalase. In: Glick D, editor. Methods of biochemichal analysis. New York: Interscience Publishers; 1954. p.408-24.
22. 22 Lowry O, Roseborough A, Farr A, Randall R. Protein measurement with Folin phenol reagent. J Biol Chem, 1951;193:265-75.
23. 23 Crosby W, Munn J, Furth F. Standardizing a method for a clinical hemoglobinometry. US Armed Forces Med J, 1954;5:693.
24. 24 Coyle J, Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science, 1993;262:689-94.
25. 25 Smith AM, Sayre LM, Monnier VM, Perry G. Oxidative posttranslational modifications in Alzheimer disease. Mol Chem Neuropathol, 1996;28:41-8.
26. 26 Thurnham DI, Titunayake RD, Koottahep S, McConkey B, Davis M. Antioxidant status measured by the TRAP assay in rheumatoid arthritis. In: Rice-Evans C, editor. Free radicals oxidative stress and drug action. London: Richelieu Press; 1987. p.169-91.
27. 27 Gatto EM, Carreras MC, Pargament GA, et al. Neutrophil function, nitric oxide and blood oxidative stress in Parkinson's disease. Mov Disorders, 1996;11:261-7.
28. 28 Cadenas E, Sies H. Low level chemiluminescence of liver microsomal fractions initiated by tert-butyl hydroperoxide. Eur J Biochem, 1982;124:349-54.
29. 29 Marklund S, Adolfsson R, Gottfries C, Winblad B. Superoxide dismutase isoenzymes in normal brains from patients with dementia of Alzheimer type. J Neurol Sci, 1985;67:319-25.
30. 30 Harris DE. Regulation of antioxidant enzymes. FASEB J, 1992;6:1675-83.